Figure 2.
The pretravel health encounter (PHE) offers better value if more travelers are unvaccinated at baseline or if more eligible travelers receive measles-mumps-rubella (MMR) vaccination at PHE. The figure shows a 2-way sensitivity analyses of the value of PHE, compared with no PHE, while modifying Riskexposure (y-axis) and the percentage of travelers unvaccinated at baseline (x-axis, A) or receiving vaccination at PHE (x-axis, B). A white X marks the base case. Horizontal lines represent the risk of exposure to measles while traveling to different continents or hot spots, from the highest (top) to lowest (bottom) risk of exposure. (A) PHE offers better value (yellow or orange) or is cost-saving (green) when Riskexposure is high (top) or when more travelers are unvaccinated at baseline (right). (B) PHE offers better value or is cost-saving if more MMR-eligible travelers are vaccinated at PHE (right), especially for travelers whose destinations have a higher Riskexposure (top). PHE is never preferred, regardless of the risk of measles exposure, when no MMR-eligible travelers receive the MMR vaccine during PHE (black). Abbreviations: ICER, incremental cost-effectiveness ratio, in US$ per measles case averted; MMR, measles-mumps-rubella; PHE, pretravel health encounter.
